GFACX
Price
$64.46
Change
+$0.58 (+0.91%)
Updated
Dec 20 closing price
TGVYX
Price
$55.03
Change
+$0.63 (+1.16%)
Updated
Dec 20 closing price
Ad is loading...

GFACX vs TGVYX

Header iconGFACX vs TGVYX Comparison
Open Charts GFACX vs TGVYXBanner chart's image
American Funds Growth Fund of Amer C
Price$64.46
Change+$0.58 (+0.91%)
VolumeN/A
CapitalizationN/A
Touchstone Growth Opportunities Y
Price$55.03
Change+$0.63 (+1.16%)
VolumeN/A
CapitalizationN/A
GFACX vs TGVYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. TGVYX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and TGVYX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 301B vs. TGVYX (172M). GFACX (0.00) and TGVYX (0.00) have matching dividends . GFACX was incepted earlier than TGVYX: GFACX (24 years) vs TGVYX (16 years). TGVYX is a more actively managed with annual turnover of: 55.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than TGVYX: GFACX (250) vs TGVYX (2500). TGVYX annual gain was more profitable for investors over the last year : 27.74 vs. GFACX (17.61). TGVYX return over 5 years is better than : 59.92 vs. GFACX (38.27).
GFACXTGVYXGFACX / TGVYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years16 years-
Gain YTD17.20027.41463%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets301B172M175,000%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.6127.7463%
Returns for 3 years-0.2626.59-1%
Returns for 5 years38.2759.9264%
Returns for 10 years58.7368.6786%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMC4.180.09
+2.20%
AMC Entertainment Holdings
VTR58.761.03
+1.78%
Ventas
JBT124.781.18
+0.95%
John Bean Technologies Corp
CMPX1.380.01
+0.73%
Compass Therapeutics
WISA1.70-0.02
-1.16%
WiSA Technologies